- Home
- ATON vs CURX Comparison
ATON vs CURX Comparison
Compare ATON & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATON | CURX |
|---|---|---|
| Founded | 1973 | 2018 |
| Country | British Virgin Islands | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 7.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | ATON | CURX |
|---|---|---|
| Price | $0.52 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.7M | 2.7M |
| Earning Date | 02-27-2026 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $3.61 |
| 52 Week High | $15.82 | $8.60 |
Technical Indicators
Market Signals| Indicator | ATON | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 32.40 |
| Support Level | $0.46 | $0.27 |
| Resistance Level | $0.59 | $0.31 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 9.62 | 11.45 |
Price Performance
Historical ComparisonAbout ATON AlphaTON Capital Corp.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
About CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.